FBTvsPBEETF Comparison
VS
First Trust NYSE Arca Biotechnology Index Fund ETF (FBT) belongs to the US Health Care segment. Invesco Dynamic Biotechnology & Genome ETF (PBE) is part of the BioTech & Genomics segment. Both ETFs have the same top 1 sector exposures: Healthcare. FBT is less expensive with a Total Expense Ratio (TER) of 0.54%, versus 0.59% for PBE. FBT is up 27.43% year-to-date (YTD) with +$964M in YTD flows. PBE performs worse with 14.29% YTD performance, and +$114M in YTD flows. Run a side-by-side ETF comparison of FBT and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FBT vs PBE performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FBT PBE | +1.52%-1.08% | +17.71%+10.60% | +27.43%+14.29% | +50.50%+32.37% | +73.13%+57.10% | +53.66%+25.03% |
| Flows | FBT PBE | +$13M+$36M | -$159M+$117M | +$964M+$114M | +$1.04B+$113M | +$626M+$62M | +$283M+$64M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FBT PBE | +22.30%+19.34% | +22.00%+19.23% | +21.10%+20.46% | +22.21%+22.56% |
| Max drawdown | FBT PBE | -4.37%-5.97% | -14.27%-11.70% | -19.92%-22.21% | -29.49%-33.32% |
| Max drawdown duration | FBT PBE | 30d8d | 126d166d | 237d324d | 1138d1509d |
Trading data
FBT | PBE | |
Last sale 9/11/2026 at 1:30 PM | $261.85 | $92.91 |
| Previous close 09/10/2026 | $262.28 | $93.03 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
FBT | PBE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
FBT | PBE | |
|---|---|---|
| Last price | $261.85 | $92.91 |
| 1D performance | -0.16% | -0.13% |
| AuM | $2.86 B | $404.80 M |
| E/R | 0.54% | 0.59% |
Characteristics
FBT | PBE | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | First Trust | Invesco |
| Benchmark | NYSE Arca Biotechnology Index | Dynamic Biotech & Genome Intellidex Index |
| N° of holdings | 30 | 30 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | June 19, 2006 | June 23, 2005 |
| ESG | No | No |
Advertisement
Exposure
Countries
FBT
USA
82.19%
Other
17.81%
PBE
USA
97.13%
Other
2.87%
Sectors
FBT
Healthcare
99.86%
Other
0.14%
PBE
Healthcare
100%
Other
0%
Advertisement
Diversification
FBT
Total weight of top 15 holdings out of 15
55.87%
PBE
Total weight of top 15 holdings out of 15
61.32%
Top 15 holdings
Data as of July 31, 2026
FBT
Halozyme Therapeutics, Inc.
4.31%
Corcept Therapeutics, Inc.
4.08%
Repligen Corp.
3.87%
Regeneron Pharmaceuticals, Inc.
3.85%
BeOne Medicines Ltd.
3.83%
BioNTech SE
3.75%
Natera, Inc.
3.73%
Amgen, Inc.
3.70%
argenx SE
3.66%
NeoGenomics, Inc.
3.63%
Genmab A/S
3.57%
BioMarin Pharmaceutical, Inc.
3.55%
Illumina, Inc.
3.47%
Vertex Pharmaceuticals, Inc.
3.45%
Gilead Sciences, Inc.
3.42%
PBE
Amgen, Inc.
5.16%
Vertex Pharmaceuticals, Inc.
4.96%
Royalty Pharma Plc
4.91%
Regeneron Pharmaceuticals, Inc.
4.90%
Biogen, Inc.
4.85%
Gilead Sciences, Inc.
4.44%
Alnylam Pharmaceuticals, Inc.
4.34%
United Therapeutics Corp.
4.06%
CareDx, Inc.
4.01%
Bio-Techne Corp.
3.66%
Illumina, Inc.
3.27%
Vericel Corp.
3.25%
Protagonist Therapeutics, Inc.
3.24%
Incyte Corp.
3.19%
Veracyte, Inc.
3.07%
Frequently asked questions about FBT and PBE
How have the FBT and PBE ETFs performed in 2026?
As of September 10, 2026, FBT is up 27.43% year-to-date (YTD), while PBE has returned 14.29%. That puts FBT better performer ahead so far this year.
Which ETF is attracting more investor money: FBT or PBE?
Year-to-date, the FBT ETF saw +$964M in flows, compared to +$114M for PBE.
Which ETF is more volatile: FBT or PBE?
Over the past year, FBT had a volatility of 22%, while PBE experienced 19.23%.
Which ETF is bigger: FBT or PBE?
As of September 10, 2026, FBT holds $2.86 B in assets under management (AUM), while PBE manages $404.80 M.
What sectors do the FBT and PBE ETFs invest in?
FBT leans toward sectors like Healthcare. Meanwhile, PBE focuses on Healthcare.
What are the top holdings of the FBT ETF and PBE ETF?
FBT top holdings include Halozyme Therapeutics, Inc., Corcept Therapeutics, Inc. and Repligen Corp.. PBE holds in its top three: Amgen, Inc., Vertex Pharmaceuticals, Inc. and Royalty Pharma Plc.
Which ETF is more diversified: FBT or PBE?
FBT holds 30 securities with 55.87% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 61.32%.
Advertisement
Latest news about FBT & PBE
Advertisement
